We are live on
!
Find out more
BHCM
Brevan Howard Capital Management Portfolio holdings
AUM
$11.3B
1-Year Est. Return
35.84%
This Fund
S&P 500
This Quarter
Est. Return
+9.65%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
–
AUM
$1.18B
AUM Growth
+$270M
(+30%)
Cap. Flow
+$244M
Cap. Flow
% of AUM
20.59%
Top 10 Holdings %
Top 10 Hldgs %
98.79%
Holding
16
New
11
Increased
1
Reduced
–
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$23.7M |
| 2 |
Petrobras
PBR
|
+$11.6M |
| 3 |
BHI
Baker Hughes
BHI
|
+$7.99M |
| 4 |
Halliburton
HAL
|
+$7.34M |
| 5 |
State Street SPDR S&P Metals & Mining ETF
XME
|
+$7.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$25M |
| 2 |
ONIT
Onity Group
ONIT
|
+$203K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 2.93% |
| 2 | Materials | 1.31% |
| 3 | Financials | 0.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $1.08B | 91.36% |
5,000,000
+1,300,000
| +35% | +$281M |
|
|
2
iShares Biotechnology ETF
IBB
$9.31B
| $24M | 2.03% |
+249,000
| New | +$23.7M |
|
|
3
Petrobras
PBR
$121B
| $12.4M | 1.04% |
+1,324,294
| New | +$11.6M |
|
4
CME Group
CME
$92.2B
| $10.7M | 0.91% |
102,553
| – | – |
|
|
BHI
5
DELISTED
Baker Hughes
BHI
| $8.38M | 0.71% |
+166,037
| New | +$7.99M |
|
|
6
Halliburton
HAL
$27.9B
| $7.54M | 0.64% |
+168,125
| New | +$7.34M |
|
|
7
State Street SPDR S&P Metals & Mining ETF
XME
$4.05B
| $7.26M | 0.61% |
+273,649
| New | +$7.34M |
|
8
SLB Ltd
SLB
$77.8B
| $6.35M | 0.54% |
+80,731
| New | +$6.41M |
|
9
Vale
VALE
$62.9B
| $6.1M | 0.52% |
+1,109,490
| New | +$6.09M |
|
10
VanEck Junior Gold Miners ETF
GDXJ
$7.06B
| $5.2M | 0.44% |
+117,342
| New | +$5.56M |
|
11
VanEck Gold Miners ETF
GDX
$23B
| $5M | 0.42% |
+189,092
| New | +$5.43M |
|
12
Alcoa
AA
$11.7B
| $4.71M | 0.4% |
+193,284
| New | +$4.71M |
|
13
Freeport-McMoran
FCX
$90B
| $4.66M | 0.39% |
+428,954
| New | +$4.93M |
|
|
14
iShares MSCI Emerging Markets ETF
EEM
$28B
| – | – |
-728,862
| Closed | -$25M |
|
|
15
PUT
iShares MSCI Emerging Markets ETF
EEM
$28B
| – | – |
-3,000,000
| Closed | -$103M |
|
|
ONIT
16
Onity Group
ONIT
$333M
| – | – |
-7,928
| Closed | -$203K |
|
Similar funds
GKIM
DCP
VLKIM
ERSOT
GIM
DWM
MIFH
Brevan Howard Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Brevan Howard Capital Management held 16 positions worth $1.18B, up 30% from $913M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Brevan Howard Capital Management deployed $244M of net new capital in Q3 2016, opening 11 new positions and adding to 1 existing holding. Its largest new stake was iShares Biotechnology ETF: 249,000 shares worth $24M.
By sector, the portfolio is most concentrated in Energy at 2.9% of assets, up from 0% a quarter earlier, followed by Materials and Financials.
On the sell side, the most notable exit was iShares MSCI Emerging Markets ETF, an estimated $25M sold.
- Brevan Howard Capital Management's largest Q3 2016 buy was iShares Biotechnology ETF: 249,000 shares worth $24M.
- Brevan Howard Capital Management fully exited iShares MSCI Emerging Markets ETF in Q3 2016, selling an estimated $25M.
- Brevan Howard Capital Management's ten largest holdings make up 99% of its $1.18B portfolio in Q3 2016.
- Brevan Howard Capital Management opened 11 new positions and closed 3 in Q3 2016.
- Brevan Howard Capital Management's portfolio value rose 30% quarter-over-quarter to $1.18B.
Based on Brevan Howard Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.